By: The Daniella Maria Arturi Foundation October 12, 2012
‘SHINE’ on DBA…! DMAF is encouraging all DBA researchers to submit proposals to the National Institute of Diabetes and Digestive and Kidney Diseases Stimulating Hematology Investigation: New Directions in Hematology Research (SHINE-II) (R01). http://grants.nih.gov/grants/guide/pa-files/PAS-13-006.html New Directions in Hematology Research (SHINE-II) (R01): This research Funding Opportunity Announcement (FOA), New Directions in Hematology Research (SHINE-II), [...] Read more »
By: The Daniella Maria Arturi Foundation
Anna Rita Migliaccio, PhD, Professor of Medicine, Hematology and Medical Oncology and member of The Tisch Cancer Institute of Mount Sinai School of Medicine, has been awarded a Research Project (R01) grant from the National Institutes of Health (NIH) for her research project “The human glucocorticoid receptor and normal and pathological terminal Erythroid.” This project, [...] Read more »
By: The Daniella Maria Arturi Foundation September 13, 2012
2012 Science and Environment Medal Recipient This medal recognizes a federal employee for a significant contribution to the nation in activities related to science and environment (including biomedicine, economics, energy, information technology, meteorology, resource conservation, and space). Neal A. Young Position: Chief of the Hematology Branch, National Heart, Lung and Blood Institute Agency: National [...] Read more »
By: The Daniella Maria Arturi Foundation April 2, 2012
The Daniella Foundation was proud to have the honor of presenting Dr. Adrianna Vlachos with the award for Best Abstract, Epidemiology for the abstract, Cancer Surveillance Defines Diamond Blackfan Anemia (DBA) As a Cancer Predisposition Syndrome Adrianna Vlachos, MD; Philip S. Rosenberg PhD; Eva Atsidaftos MA; Blanche P. Alter MD, MPH; Jeffrey M. Lipton MD, [...] Read more »
By: The Daniella Maria Arturi Foundation September 2, 2011
NIH Wants To Hear from You! NIH Seeks Comments on Proposed Common Fund Programs Deadline: September 14 The NIH Common Fund supports exceptionally innovative programs that are inherently high-risk but have the potential for high-payoff by catalyzing research across NIH and in the Biomedical research community. New ideas for Common Fund programs are identified [...] Read more »
By: The Daniella Maria Arturi Foundation
New Innovator Awards Program: Up to $1.5 million in direct costs over 5 years For early career stage investigators (ESI), defined as those who have not received an NIH R01 or similar grant and are within 10 years of completing their terminal research degree or medical residency. The deadline for submitting Award [...] Read more »
By: The Daniella Maria Arturi Foundation
The Director’s Pioneer Awards Program: NIH welcomes proposals for 2012 NIH Director’s Pioneer Awards for innovative approaches to major challenges in biomedical or behavioral research. NIH expects to make at least 7 Pioneer Awards in summer 2012. To continue its strong record of diversity [...] Read more »
By: The Daniella Maria Arturi Foundation June 17, 2011
GOP lawmakers: Spare NIH from cuts By Ian Swanson 05/27/11 A group of Republican lawmakers has asked appropriators to avoid making deep cuts to the budget of the National Institutes of Health. The request that NIH be spared highlights the difficult choices facing the GOP as it moves from writing a budget to wringing out [...] Read more »
By: The Daniella Maria Arturi Foundation April 14, 2011
Seminars in Hematology Volume 48, Issue 2 Pages 73 – 144 (April 2011) Diamond Blackfan Anemia and Ribosome Biogenesisess Edited by Benjamin Ebert MD, PhD, Jeffrey M. Lipton MD, PhD Diamond Blackfan Anemia and Ribosome Biogenesis: Introduction Benjamin Ebert, Jeffrey M. Lipton Patient Advocacy in Diamond Blackfan Anemia: Facilitating Translational Research and Progress Towards the [...] Read more »
By: The Daniella Maria Arturi Foundation March 16, 2011
March 15, 2011 NIH’s Therapeutics for Rare and Neglected Disease (TRND) program has announced its second solicitation for collaborative projects. The due date for applications is April 26, 2011. Details and forms can be found at the TRND website andProposalCentral . TRND is intended to stimulate research collaborations between intramural NIH drug development scientists and research partners such [...] Read more »